BioCorRx (BICX) Return on Capital Employed (2011 - 2026)
BioCorRx (BICX) posted Return on Capital Employed of 114.48% for Q1 2026, down 44.49% sequentially from 206.22% in Q4 2025, and up 6279.0% YoY from 1.79% in Q1 2025.
BioCorRx (BICX) Return on Capital Employed (2011 - 2026) Analysis & Trends
BioCorRx has reported Return on Capital Employed for 16 years, with the latest figure at 114.48% in Q1 2026.
- Quarterly Return on Capital Employed rose 6279.0% year-over-year to 114.48% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 114.48% (up 6279.0% YoY) and the FY2025 annual result came in at 68.63%, up 313.0% from the prior year.
- Return on Capital Employed slipped to 114.48% in Q1 2026 per BICX's latest filing, from 206.22% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 206.22% in Q4 2025 and troughed at 46.52% in Q3 2025.
- A 5-year average of 87.04% and a median of 78.3% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed tumbled 85387 bps in 2022, then jumped 13964 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 102.78% in 2022, then tumbled by 38 bps to 63.45% in 2023, then climbed by 5 bps to 66.59% in 2024, then soared by 210 bps to 206.22% in 2025, then tumbled by 44 bps to 114.48% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 114.48%, 206.22%, and 46.52% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | -16.87% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 17.89% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.50% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 14.43% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 9.75% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 16.45% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 8.91% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 28.21% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 14.52% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.48% |
| Dec 31, 2025 | 206.22% |
| Sep 30, 2025 | -46.52% |
| Jun 30, 2025 | 65.70% |
| Mar 31, 2025 | 51.69% |
| Dec 31, 2024 | 66.59% |
| Sep 30, 2024 | 62.90% |
| Jun 30, 2024 | 59.60% |
| Mar 31, 2024 | 54.29% |
| Dec 31, 2023 | 63.45% |
| Sep 30, 2023 | 78.30% |
| Jun 30, 2023 | 84.88% |
| Mar 31, 2023 | 90.51% |
| Dec 31, 2022 | 102.78% |
| Sep 30, 2022 | 133.12% |
| Jun 30, 2022 | 144.26% |
| Mar 31, 2022 | 147.38% |
| Dec 31, 2021 | 173.07% |
| Sep 30, 2021 | 239.48% |
| Jun 30, 2021 | 998.12% |